In Silico Analysis of Enantioselective Binding of Pomalidomide Targets for Multiple Myeloma
Chirality. 2026 Aug;38(8):e70125. doi: 10.1002/chir.70125.ABSTRACTPomalidomide is a 2nd-generation chiral immunomodulatory (IMiDs) drugs and have antiangiogenic activity. Despite being teratogenic, it has been shown to be effective in treating multiple myeloma. Enantioselectivity, chemical structure

